Exactly. IPIX phase 2 trials, all successful across the pipeline to date have been specifically designed to show the potential of a robust phase 3. WITH a partnership being very likely.
Don't get lazy on this puppy people.
DO YOUR DD.
While there is no specific timeline for a partnership, brilacidin is likely in first place. Kevetrin could come out of nowhere. Prurisol data any day to a few more weeks.
BP knows what they're looking for here. Just a bit of patience imo. But of course I already own shares.